Q & M Dental Group (Singapore) Limited (QC7.SI)
SGD 0.3
(0.0%)
SGD 0.3
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 39.69 Million SGD | -1.84% |
| 2022 | 35.78 Million SGD | -32.06% |
| 2021 | 63.72 Million SGD | 56.93% |
| 2020 | 37.79 Million SGD | 26.51% |
| 2019 | 39.26 Million SGD | 45.75% |
| 2018 | 15.93 Million SGD | 22.85% |
| 2017 | 30.9 Million SGD | -26.72% |
| 2016 | 26.68 Million SGD | 4.65% |
| 2015 | 20.78 Million SGD | 44.77% |
| 2014 | 14.39 Million SGD | 86.72% |
| 2013 | 7.65 Million SGD | 13.47% |
| 2012 | 7.07 Million SGD | 13.72% |
| 2011 | 6.34 Million SGD | 22.5% |
| 2010 | 5.21 Million SGD | 8.79% |
| 2009 | 4.69 Million SGD | 3.89% |
| 2008 | 4.52 Million SGD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 7.4 Million SGD | 2.36% |
| 2024 Q2 | 7.4 Million SGD | 0.0% |
| 2023 Q2 | - SGD | 0.0% |
| 2023 Q3 | 7.23 Million SGD | 0.0% |
| 2023 Q1 | - SGD | -100.0% |
| 2023 Q4 | 7.23 Million SGD | 0.0% |
| 2023 FY | - SGD | -1.84% |
| 2022 Q3 | 9.42 Million SGD | 4.26% |
| 2022 Q1 | 12.87 Million SGD | 21.37% |
| 2022 Q2 | 9.03 Million SGD | -29.8% |
| 2022 Q4 | 9.1 Million SGD | -3.38% |
| 2022 FY | - SGD | -32.06% |
| 2021 Q4 | 10.6 Million SGD | -50.67% |
| 2021 Q1 | 10.61 Million SGD | -9.45% |
| 2021 FY | - SGD | 56.93% |
| 2021 Q3 | 21.5 Million SGD | 28.07% |
| 2021 Q2 | 16.79 Million SGD | 58.17% |
| 2020 FY | - SGD | 26.51% |
| 2020 Q1 | 6.22 Million SGD | 58.45% |
| 2020 Q2 | 10.3 Million SGD | 65.49% |
| 2020 Q3 | 9.68 Million SGD | -6.0% |
| 2020 Q4 | 11.72 Million SGD | 21.1% |
| 2019 Q4 | 3.92 Million SGD | -54.56% |
| 2019 Q3 | 8.64 Million SGD | -4.81% |
| 2019 Q1 | 8.32 Million SGD | 132.17% |
| 2019 FY | - SGD | 45.75% |
| 2019 Q2 | 9.08 Million SGD | 9.05% |
| 2018 Q2 | 6.12 Million SGD | 8.53% |
| 2018 FY | - SGD | 22.85% |
| 2018 Q4 | 3.58 Million SGD | -31.36% |
| 2018 Q3 | 5.22 Million SGD | -14.61% |
| 2018 Q1 | 5.63 Million SGD | 149.73% |
| 2017 Q2 | 3.37 Million SGD | -43.12% |
| 2017 Q1 | 5.93 Million SGD | 266.93% |
| 2017 FY | - SGD | -26.72% |
| 2017 Q4 | 2.25 Million SGD | -56.35% |
| 2017 Q3 | 5.17 Million SGD | 53.18% |
| 2016 Q1 | 7.21 Million SGD | 72.66% |
| 2016 FY | - SGD | 4.65% |
| 2016 Q4 | 1.61 Million SGD | -76.09% |
| 2016 Q2 | 7.25 Million SGD | 0.61% |
| 2016 Q3 | 6.76 Million SGD | -6.74% |
| 2015 Q4 | 4.17 Million SGD | -33.11% |
| 2015 FY | - SGD | 44.77% |
| 2015 Q3 | 6.24 Million SGD | 10.51% |
| 2015 Q2 | 5.65 Million SGD | -1.93% |
| 2015 Q1 | 5.76 Million SGD | -8.71% |
| 2014 Q4 | 6.31 Million SGD | 35.04% |
| 2014 Q3 | 4.67 Million SGD | 155.83% |
| 2014 Q2 | 1.82 Million SGD | -19.52% |
| 2014 FY | - SGD | 86.72% |
| 2014 Q1 | 2.27 Million SGD | -7.57% |
| 2013 Q4 | 2.45 Million SGD | 8.29% |
| 2013 FY | - SGD | 13.47% |
| 2013 Q2 | 1.54 Million SGD | -14.9% |
| 2013 Q1 | 1.81 Million SGD | -24.12% |
| 2013 Q3 | 2.26 Million SGD | 47.08% |
| 2012 Q4 | 2.38 Million SGD | 55.47% |
| 2012 Q3 | 1.53 Million SGD | -6.17% |
| 2012 FY | - SGD | 13.72% |
| 2012 Q2 | 1.63 Million SGD | 8.34% |
| 2012 Q1 | 1.51 Million SGD | -32.54% |
| 2011 Q4 | 2.24 Million SGD | 92.11% |
| 2011 Q2 | 1.57 Million SGD | 15.49% |
| 2011 Q3 | 1.16 Million SGD | -25.87% |
| 2011 FY | - SGD | 22.5% |
| 2011 Q1 | 1.36 Million SGD | 1.57% |
| 2010 Q4 | 1.34 Million SGD | 11.66% |
| 2010 Q1 | 1.04 Million SGD | 0.0% |
| 2010 Q2 | 1.48 Million SGD | 41.99% |
| 2010 FY | - SGD | 8.79% |
| 2010 Q3 | 1.2 Million SGD | -18.91% |
| 2009 FY | - SGD | 3.89% |
| 2008 FY | - SGD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Raffles Medical Group Ltd | 132.88 Million SGD | 70.127% |